Phase 2 Data on Provectus’s PV-10 for Metastatic Melanoma Will Be Presented at the 2011 International Melanoma Congress on November 12, 2011

  • Home
  • Cura
  • Phase 2 Data on Provectus’s PV-10 for Metastatic Melanoma Will Be Presented at the 2011 International Melanoma Congress on November 12, 2011

Provectus Pharmaceuticals, Inc. (OTCBB:PVCThttps://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at the 2011 International Melanoma Congress on November 12, 2011, during the 5th Meeting of Interdisciplinary Melanoma/Skin Cancer Centres meeting.

Read more …

Condividi il Post:

Post Correlati